DarioIQ drives higher engagement and retention, better clinical outcomes, higher client ROI and recurring revenue growth for Dario Dario IQ's AI-driven personalization increases member engagement by 40% and improves member retention by 20% by leveraging 13+ billion proprietary real-world healthcare data points NEW YORK, July 13, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company," "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the man

DUBLIN, July 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced the publication of a new manuscript about the use of Acthar Gel (repository corticotropin injection) to treat certain severe autoimmune diseases. Sponsored by Keenova, the retrospective, physician-reported, survey-based medical chart review study covered in the manuscript used real‑world clinical data to evaluate patient characteristics, treatment patterns, and physicians' assessments of outcomes among individuals with rheu

Fully rechargeable: First fully rechargeable active bone conduction sound processor, with up to 30 hours of battery life on a single charge. †,7-9 Improved power and sound quality: Improved clarity and sound quality, enhanced by the new signal processing platform and powerful lithium-ion battery. Now with fitting range up to 65 dB HL bone conduction thresholds in the mid to high frequencies.¥, 10 A range of streaming options: Joins Cochlear's industry-leading connectivity with streaming from A

The program is designed to enable Pulsenmore to develop and clinically validate AI applications that improve clinical workflow efficiency and enhance the scalability of the company's home ultrasound platform. RAMAT GAN, Israel, July 13, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in connected home ultrasound technology, today announced that it has been selected to participate in Israel's Healthcare AI Regulatory Sandbox Program, established by the Israel Innovat

UC San Diego Health surgeons and wildlife health experts at the San Diego Zoo Safari Park team up to perform the world's first reported mastoidectomy on a gorilla SAN DIEGO, July 13, 2026 /PRNewswire/ -- Mizani, a 12-year-old male western lowland gorilla at the San Diego Zoo Safari Park, underwent a first-of-its-kind mastoidectomy to treat an infection that had spread into portions of his skull. The surgery was performed by a multidisciplinary team of wildlife health experts from the San Diego Z

Fulfills important regulatory milestone for AP-SA02 on the path toward a future BLA and supports expansion into pediatric patients LOS ANGELES, July 13, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced that it has

Collaboration intended to support broader awareness of NetraMark's clinical development initiatives and NetraAI platformTORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Company" or "NetraMark") (TSX: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), an artificial intelligence company transforming clinical trials with AI-powered precision analytics in the pharmaceutical industry, today announced it has engaged AM Public Relations (AM PR), a healthcare-focused public relations agenc

-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline of 35.3% in the prespecified mITT analysis -- -- 40.0% of patients achieved SALT-20 response at Week 36 in the mITT analysis and 30.3% of patients achieved SALT-20 response at Week 36 in the ITT analysis of all enrolled patients -- -- Generally well-tolerated safety profile, consistent with prior studies, with no new safety signals -- -- Bempikibart demonstrated a

New app functions empower patients, caregivers and health care professionals to easily find and access Karmanos' large portfolio of innovative cancer treatment options through actively recruiting clinical trials DETROIT, July 13, 2026 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute has released a new and improved version of the KCI Clinical Trials App on both the Apple App Store and the Google Play Store. The apps' new features, launched on June 12, improve usability, accessibility an

Encouraging Data Demonstrating Target Engagement will be Presented in a Poster on Monday July 13ᵗʰ CLEVELAND, July 13, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, will be presenting data from its recently completed Phase 2a clinical trial in Alzheimer's Disease (AD) at the Alzheimer's Association International Conference (AAIC) 2026 during the Monday July 13th poster session. The trial was a 28-day, multi